ArticleJournal of Taibah University Medical Sciences2024
Thyroid cancer and Hashimoto's thyroiditis in AUS/FLUS nodules: is there a correlation? A retrospective study.
Article in Journal of Taibah University Medical Sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The global prevalence of Hashimoto's thyroiditis (HT) and differentiated thyroid cancer (DTC), particularly papillary thyroid cancer (PTC), is increasing. However, studies assessing correlations between these diseases have yielded inconsistent findings. Furthermore, patients diagnosed with HT show a higher prevalence of indeterminate cytology than those without HT. This study was aimed at assessing the interaction between HT and DTC in patients undergoing thyroidectomy for indeterminate thyroid nodules (ITNs), and investigating the role of repeated fine-needle aspiration cytology (FNAC) in ITNs with HT. Methods: This retrospective study enrolled 111 consecutive patients who underwent thyroidectomy for ITNs over a 4-year period. The outcome measures included demographic information; numbers and diagnoses of FNAC; risk of malignancy; serum thyroid-stimulating hormone levels; ultrasound features; and features of aggressiveness, including lymphovascular invasion, extrathyroidal extension and lymph node metastasis. Results: Among the participants, 76.6 % were women, and 46.8 % had malignant pathology. Overall, HT did not increase malignancy risk, according to the final histopathology. However, the presence of HT significantly increased the probability of a PTC diagnosis with repeated FNAC (odds ratio = 9.3; 95 % confidence interval: 1.0-96.3). Furthermore, significant correlations were observed between malignant nodules with HT and age, sex, lymph node metastasis and positive margins. Conclusions: Overall, HT did not increase malignancy risk in the final pathology of ITNs but did increase the risk of a cytological PTC diagnosis with repeated FNAC. Because this study was based in a local community setting, large, collaborative, multicenter studies are required to validate our findings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.